Regulatory oversight and monitoring – Uranium and nuclear substance processing facilities and research reactors
The Canadian Nuclear Safety Commission (CNSC) evaluates the safety performance of uranium and nuclear substance processing facilities and of research reactors, focusing on 3 safety and control areas (SCAs): radiation protection, environmental protection, and conventional health and safety. Regulatory oversight and monitoring provides ratings for all 14 SCAs and addresses reportable events, significant facility modifications and other matters of regulatory interest.
Regulatory oversight and monitoring activities focus on the following facilities:
- Uranium processing facilities: Cameco Blind River Refinery, Cameco Port Hope Conversion Facility, Cameco Fuel Manufacturing Inc., and BWXT Nuclear Energy Canada Inc. (formerly GE Hitachi Nuclear Energy Canada, including BWXT Nuclear Energy Canada Peterborough, and BWXT Nuclear Energy Canada Toronto)
- Nuclear substance processing facilities: SRB Technologies (Canada) Inc., Nordion (Canada) Inc., BWXT Medical Ltd. and Best Theratronics Limited
- Research reactors: McMaster Nuclear Reactor, Royal Military College of Canada SLOWPOKE-2 reactor, and École Polytechnique de Montréal SLOWPOKE-2 reactor
Report: Oversight data and analysis
Past reports
View past reports on uranium and nuclear substance processing facilities and on research reactors (reporting on research reactors can be viewed in the 2020 and 2023 reports):
Related links
- Safety and control areas
- Rating definitions
- Scientific and technical information
- Mythbusters: Clarifying common misperceptions about uranium processing
Contact us
Email info@cnsc-ccsn.gc.ca for information about CNSC regulatory activities, inquiries and support, or if you need the information in an alternate format.
Page details
- Date modified: